return to news
  1. Gaudium IVF and Women Health share price: Stock lists at 5% premium on NSE, BSE; here's how much investors made

Market News

Gaudium IVF and Women Health share price: Stock lists at 5% premium on NSE, BSE; here's how much investors made

Kamal Joshi

2 min read | Updated on February 27, 2026, 09:45 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Gaudium IVF and Women Health share price: The ₹165 crore initial public offering was a mix of new shares valued at ₹90 crore and an offer for sale (OFS) component aggregating to ₹75 crore by promoter Dr Manika Khanna.

Gaudium IVF and Women Health share price: It provides In Vitro Fertilisation (IVF) treatments. | Image: gaudiumivfcentre.com

Gaudium IVF and Women Health Ltd provides In Vitro Fertilisation (IVF) treatments. | Image: gaudiumivfcentre.com

Gaudium IVF and Women Health share price: Shares of fertility services provider Gaudium IVF and Women Health listed at ₹83 apiece on the National Stock Exchange (NSE) and the BSE on Friday, February 27.

Open FREE Demat Account within minutes!
Join now

This reflects a premium of 5.06% over the issue price of ₹79 per share.

Gaudium IVF and Women Health share price: Here's how much investors made per lot

A lot consisted of 189 shares. Investors who received Gaudium IVF and Women Health IPO allotment made ₹15,687 per lot.

The ₹165 crore initial public offering was a mix of new shares valued at ₹90 crore and an offer for sale (OFS) component aggregating to ₹75 crore by promoter Dr Manika Khanna.

Proceeds from the fresh issue will be used to establish 19 new In Vitro Fertilisation (IVF) centres across India, along with repayment of certain borrowings and for general corporate purposes.

PNGS Reva Diamond Jewellery IPO allotment: How to check status online on Bigshare Services, NSE, BSE

The initial public offering was booked 7.27 times, as it mobilised bids for 10,63,50,489 equity shares against 1,46,20,340 shares on offer, according to the consolidated data on the NSE website.

CategoryReservedNo of Shares Bid ForNo of Times
Qualified Institutional Buyers41,77,24067,85,4781.62
Non-Institutional Investors31,32,9304,40,22,06914.05
Retail Individual Investors73,10,1705,55,42,9427.60
Total1,46,20,34010,63,50,4897.27

Prior to the IPO, the firm secured ₹49.5 crore in the anchor round from investors including MERU Investment Fund PCC-CELL, Carnelian India Multi Strategy Fund, Sanshi Fund I and Hornbill Orchid India Fund. The company allocated 62,65,860 shares to these investors at ₹79 apiece.

Founded by Khanna, Gaudium IVF offers IVF treatments in India. It operates through a hub-and-spoke model, with seven hubs and 28 spokes across multiple states.

On the financial front, the company recorded revenue from operations of ₹70.72 crore and a profit after tax of ₹19.13 crore for the financial year 2024-25. In FY24, revenue and profit stood at ₹47.89 crore and ₹10.31 crore, respectively.

To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.

To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Kamal Joshi
Kamal Joshi is a business journalist who covers industries, markets, and IPOs. He is passionate about breaking news and enjoys playing tennis, especially flexing his backhand. He was previously associated with Republic TV and LatestLY.

Next Story